Understanding kidney damage caused by increased filtration in kidney transplants
Defining the molecular landscape of hyperfiltration-mediated glomerular injury using kidney allografts as a model system
This study is looking at how too much filtering in kidney transplants can harm the organ, and it's for anyone interested in understanding kidney health, especially those with diabetes, as it aims to find out what happens at the cellular level when kidneys get damaged.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11000309 on NIH RePORTER |
What this research studies
This research investigates how increased filtration in kidney transplants leads to damage and failure of the organ. By analyzing kidney allografts, the study aims to uncover the molecular mechanisms that contribute to podocyte detachment, a key factor in kidney injury. The researchers will utilize advanced techniques like RNA sequencing to identify specific gene signatures and cellular interactions involved in this process. Additionally, they will explore whether similar mechanisms occur in diabetic patients experiencing hyperfiltration.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with kidney transplants or those suffering from diabetes-related kidney issues.
Not a fit: Patients with acute kidney injury or those without a history of kidney transplants or diabetes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for prolonging the lifespan of kidney transplants and better management of kidney diseases.
How similar studies have performed: Previous research has shown promising results in understanding kidney disease mechanisms, suggesting that this approach could yield valuable insights.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Naik, Abhijit S — University of Michigan at Ann Arbor
- Study coordinator: Naik, Abhijit S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.